Every SEC Form 3/4/5 on record for this filer (CIK 1531178) — 7 issuers, 37 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | Director | 2025-11-04 → 2025-11-04 | 2 | — |
| XERS | Xeris Biopharma Holdings, Inc. | See Remarks · Director · lapsed | 2018-06-20 → 2024-01-31 | 22 | $1M |
| MIST | Milestone Pharmaceuticals Inc. | Director · lapsed | 2019-05-08 → 2020-06-08 | 2 | — |
| ITRM | Iterum Therapeutics plc | Director · lapsed | 2018-05-24 → 2019-05-29 | 5 | $5,220 |
| PDLI | PDL BIOPHARMA, INC. | Director · lapsed | 2015-09-08 → 2018-06-12 | 5 | — |
| SCMP | Sucampo Pharmaceuticals, Inc. | Director · lapsed | 2016-08-03 → 2018-02-13 | 5 | — |
| NEOS | Neos Therapeutics, Inc. | Director · lapsed | 2015-07-22 → 2017-07-05 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| XERS | 2023-08-09 | Buy | 10,000 | $2.38 | $23,800 | 2,288,064 |
| XERS | 2022-12-13 | Buy | 20,000 | $1.45 | $29,000 | 1,528,064 |
| XERS | 2022-05-12 | Buy | 100,000 | $1.40 | $140,000 | 1,508,064 |
| XERS | 2021-11-15 | Buy | 20,000 | $2.28 | $45,600 | 33,430 |
| XERS | 2021-11-11 | Buy | 200,000 | $2.08 | $416,000 | 808,064 |
3 of 7 issuers are covered and open a security page; the rest are on file here only.
